Lactation drug could reduce breast cancer risk after childbirth, study suggests
An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth. Cabergoline, a medication used to stop milk production after pregnancy loss or when breastfeeding is not possible, is generally well tolerated by patients with few side effects. But it may also offer unexpected benefits.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Menopause is a biological transition that's become a lucrative consumer business
United Kingdom
-
Why it's still hard to get the right over-the-counter hearing aid
United Kingdom
-
How the biggest Alzheimer's risk gene disrupts the process of insulating neurons
United Kingdom
-
Early nicotine exposure alters immune development and worsens later flu infections in mice
United Kingdom
-
Ultra-processed food intake linked to possible signs of silent strokes
United Kingdom
-
DIY health care is on the rise—here's why it's so dangerous
United Kingdom
-
Cannabis doesn’t make you violent – despite what recent reports have claimed
Australia
-
Study finds a lower cancer risk after obesity surgery regardless of age or sex
United Kingdom